What is the half-life of Dihexa?

Dihexa has a half-life of Unknown, which is why it's typically administered As needed for optimal therapeutic effect.

How do I reconstitute Dihexa?

Add bacteriostatic water to the peptide vial slowly down the side. Typical reconstitution uses 2-3ml of water for a 5mg vial. Gently swirl, do not shake.

What is the half-life of Dihexa?

Dihexa has a half-life of Unknown, which is why it's typically administered As needed for optimal therapeutic effect.

How do I reconstitute Dihexa?

Add bacteriostatic water to the peptide vial slowly down the side. Typical reconstitution uses 2-3ml of water for a 5mg vial. Gently swirl, do not shake.

Healing & Recovery

Preclinical

Dihexa

Also known as: PNB-0408, Hepatocyte Growth Factor Mimetic

Overview

Key Facts

Primary Goal: Research and therapeutic applications of Dihexa

Binds hepatocyte growth factor (HGF) receptor c-Met to augment signaling. Potently stimulates dendritic spine formation and synaptogenesis.

Dosing Information

Half-Life

~6 hours (estimated)

Typical Dose

10–40 mg

Frequency

1x daily (oral or intranasal)

Cycle Length

2-4 weeks, with breaks

Administration Routes:

subcutaneousoral

Benefits

Profoundly augments synaptic connectivity and spinogenesis
Neuroprotective against neurotoxin-induced damage
Improves memory and cognitive function in animal models
Promotes hepatocyte growth factor (HGF) signaling for brain repair
Potential application in traumatic brain injury recovery

Side Effects

Headacheuncommonmild

Mild anxiety or overstimulationuncommonmild

Insomnia if taken late in the dayuncommonmild

Blood pressure changes (theoretical, angiotensin-related)uncommonmild

Long-term safety profile unknownuncommonmild

Mechanism of Action

Binds hepatocyte growth factor (HGF) receptor c-Met to augment signaling

Potently stimulates dendritic spine formation and synaptogenesis

Activates the HGF/c-Met/PI3K pathway for neuronal survival

Resistant to enzymatic degradation by peptidases

Crosses the blood-brain barrier via oral administration

Contraindications

Do not use this peptide if any of the following apply:

Active cancer (HGF/c-Met pathway involved in tumour growth)
Pregnancy or breastfeeding
Uncontrolled hypertension
History of psychiatric disorders (may exacerbate anxiety)

Storage & Reconstitution

Unreconstituted (Powder)

Temperature2–8°C (36–46°F)

DurationUp to 3 months

Reconstituted (Mixed)

Temperature2–8°C (36–46°F)

Duration2-4 weeks

Research Summary

Preclinical

Developed by Dr. Joseph Harding and colleagues at Washington State University. Published preclinical data demonstrates remarkable cognitive enhancement in scopolamine-impaired and aged rats. No human clinical trials completed. Patent filed for neurodegenerative disease applications. Safety profile in humans remains uncharacterized.

Frequently Asked Questions

Common questions about Dihexa

UK-Specific Information

Exclusive data points and guidance for UK residents using Dihexa

UK Lab Testing

Recommended labs: Medichecks, Thriva (£89-£149 for peptide safety panel)

Generate a trackable link to share this peptide information on TikTok